Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Recce Pharmaceuticals Ltd. (ASX: RCE) has requested a trading halt on its securities as it prepares to make a significant announcement regarding its Phase 3 Diabetic Foot Ulcer Infection Approval. The halt will remain until December 9, 2024, or until the announcement is released, creating anticipation among investors about the company’s future prospects.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
